PeterAnthonyPintoMD

Director of the Urologic Oncology Fellowship Program at the National Cancer Institute. Investigator and faculty member in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Md

Join to view full profile

Dr. Pinto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pinto's full profile

Already have an account?

Office
Building 10, Hatfield CRC
Room 2W-5940
Bethesda, MD 20892
Phone+1 240-858-7200

Education & Training

Zucker School of Medicine at Hofstra/NorthwellResidency, Urology, 1997 - 2001
Zucker School of Medicine at Hofstra/NorthwellResidency, Surgery, 1995 - 1997
SUNY Upstate Medical UniversityClass of 1995

Certifications & Licensure

NY State Medical License 1997 - 2026
MD State Medical License 2002 - 2005
American Board of Urology Urology

Clinical Trials

MR Image Guided Therapy in Prostate Cancer Start of enrollment: 2011 Aug 12
Completed
Phase 2
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy Start of enrollment: 2014 May 31
Completed
Phase 2
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland Start of enrollment: 2021 Jul 23
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer Start of enrollment: 2024 May 07
Recruiting
Not Applicable
Roles: Study Chair, Contact
Join now to see all

Publications & Presentations

PubMed

Impact of Discordance Between MRI and US Volume Measurements on Prostate Fusion Biopsy Outcomes.
Tabea Borde, Nicole A Varble, Lindsey A Hazen, Laetitia Saccenti, Charisse Garcia
The Journal of Urology. 2024-12-10
A Prostate Imaging-Reporting and Data System version 2.1-based predictive model for clinically significant prostate cancer diagnosis.
David G Gelikman, William S Azar, Enis C Yilmaz, Yue Lin, Luke A Shumaker
BJU International. 2024-12-09
1 citations
Castration Levels of Testosterone Results in Atrophy of Androgen-Sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.
Nityam Rathi, Zoë Blake, Jason Hyman, Daniel R Nemirovsky, David G Gelikman
Urology. 2024-10-18

Journal Articles

Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling
Maria J Merino, Thomas P Frye, Raju Chelluri, Peter A Pinto, Abhinav Sidana, The Journal of Urology

Press Mentions

For Prostate Biopsy, It’s Best to Combine Old and New MethodsMarch 6th, 2020
Focus on Faculty with Abhinav Sidana, MDSeptember 28th, 2017
‘Targeted’ Biopsy Could Better Identify Aggressive Prostate CancersJanuary 29th, 2015
Join now to see all